Market revenue in 2023 | USD 675.9 million |
Market revenue in 2030 | USD 1,034.3 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-house, Outsourcing |
Key market players worldwide | Genpact Ltd, Criterium Inc., Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Labcorp Holdings Inc, FREYR Battery Inc, Pharmexon, Cambridge Design Partnership, Voisin Consulting Life Sciences, Accell, PAREXEL, Promedica International, PharmaLex, NDA Regulatory Service GmbH, QVigilance, BlueReg Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.13% in 2023. Horizon Databook has segmented the Germany regulatory affairs market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is one of the largest pharmaceutical markets in the world after the U.S., Japan, and France according to a report by Deloitte and this is one of the major factors responsible for the high demand for regulatory services.
Presence of skilled and experienced workforce is also one of the primary factors expected to drive the Regulatory affairs market in Germany as productivity rates are 10% higher than the average of EU15 countries.
The Federal Institute for Drug and Medical Devices and Paul-Ehrlich-Institute are the two executive agencies under Ministry of Health, which regulate the process of drug development from clinical trial application to post market approvals.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into Germany regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account